Gitar
Builds AI agents for code review and continuous integration workflows
$9MUndisclosed
Role not disclosedActivity from announced rounds
Venrock is the venture manager whose own Encoded portfolio identifies investor Bryan Roberts.
Encoded develops neurological gene therapies. Other recorded companies include Gitar’s software-review agents and Adcendo’s targeted cancer medicines. Venrock Healthcare Capital Partners remains a separate manager identity.